Earnings Call Transcripts
Access detailed transcripts and key takeaways from company earnings calls
All Earnings Calls
Fortinet Q3 2025 Earnings Call - SaaS Growth Surges While Service Revenue Trails, Backed by Unified Security Platform
Fortinet delivered strong Q3 2025 results with 14% growth in billings and revenue, led by a staggering 100% increase in Fortinet SaaS billings. The company highlighted its unique FortiOS single operat...
- Fortinet’s billings and revenue each grew 14% year-over-year in Q3 2025, demonstrating broad-based demand.
- Fortinet SaaS billings more than doubled (100%+ growth), marking the company as one of the fastest-growing SaaS players at scale.
- The FortiOS single operating system uniquely integrates firewall, SD-WAN, and SaaS functions in one platform for easy upsell and deployment.
- +12 more takeaways
Cytokinetics Q3 2025 Earnings Call - Aficamten Launch Readiness Peaks Amid Regulatory Milestones
Cytokinetics delivered a pivotal quarter focused on commercial and regulatory preparation for Aficamten, targeting potential U.S. FDA approval by year-end 2025 and EMA decision by mid-2026. Key clinic...
- Cytokinetics expects potential FDA approval of Aficamten for OHCM by end of 2025, with EMA decision anticipated in first half of 2026.
- Positive Phase 3 Maple HCM trial results demonstrated Aficamten's superiority over metoprolol, challenging current beta-blocker treatment paradigms.
- The company completed all FDA GCP inspections with no observations and does not anticipate pre-approval inspections, indicating regulatory confidence.
- +7 more takeaways
Cardlytics Q3 2025 Earnings Call - Navigating Content Restrictions and Shifting Partnerships to Sustain Growth
Cardlytics reported Q3 2025 results that aligned with expectations amid significant headwinds from content restrictions imposed by its largest financial institution (FI) partner. Billings declined 20....
- Q3 billings were $89.2 million, down 20.3% year-over-year due to content restrictions by largest FI partner.
- Cardlytics mitigated supply loss by shifting volume to a partner network 2.5 times larger than its biggest FI alone.
- Management highlights a 30% workforce reduction and $26 million in annualized cost savings to preserve financial health.
- +12 more takeaways
ACADIA Pharmaceuticals Q3 2025 Earnings Call - Strategic Salesforce Expansion and Pipeline Momentum Drive Confidence in Growth
ACADIA Pharmaceuticals reported solid Q3 2025 results with total revenues of $278.6 million, up 11% year-over-year. The commercial portfolio was led by Daybue (debut) achieving $101.1 million in net s...
- ACADIA delivered $278.6 million in Q3 revenue, up 11% year-over-year, driven by strong commercial execution.
- Daybue (debut) net sales reached $101.1 million with the highest number of unique patients treated globally at over 1,000.
- New Plasid achieved record net sales of $177.5 million, marking its strongest quarterly performance ever with 12% year-over-year growth.
- +7 more takeaways
Safehold Q3 2025 Earnings Call - Affordable Housing Drives Portfolio Growth Amid Litigation Challenge
Safehold delivered steady third quarter results with $96.2 million in revenue and earnings per share rising 12% excluding non-recurring items. The firm funded $58 million in new ground leases, focusin...
- Safehold originated eight multifamily ground leases totaling $76 million, focused entirely on affordable housing in Los Angeles and San Diego.
- Repeat customers are fueling growth in the affordable housing segment, which management views as a key expansion channel.
- Total portfolio at quarter-end was $7 billion, with unrealized capital appreciation (UCA) estimated at $9.1 billion and a loan-to-value ratio (GLTV) of 52%.
- +9 more takeaways
The Honest Company Q3 2025 Earnings Call - Launch of Transformation 2.0 to Refocus and Improve Profitability Amid Diaper Category Headwinds
The Honest Company reported mixed third-quarter results, with revenue declining 7% to $93 million, under pressure from the diaper and apparel categories amid a challenging consumer environment. Despit...
- Q3 revenue declined 7% to $93 million, hurt by diapers, apparel, and Honest.com.
- Positive net income (~$1 million) and adjusted EBITDA ($4 million) achieved for third straight quarter.
- Wipes and baby personal care categories drove growth with strong double-digit consumption increases.
- +10 more takeaways
HubSpot Q3 2025 Earnings Call - AI Integration and Platform Consolidation Drive Durable Growth
HubSpot delivered a robust Q3 2025, with 18.4% revenue growth year over year in constant currency, hitting $810 million and maintaining a solid 20% operating margin. The company's growth is underpinne...
- HubSpot reported 18.4% revenue growth YoY in constant currency, reaching $810 million in Q3 2025.
- Operating margin improved to 20%, showcasing balanced growth and profitability.
- Total customers increased by 10,900, bringing the base to nearly 279,000, up 17% YoY.
- +12 more takeaways
Deluxe Q3 2025 Earnings Call - Accelerated Debt Reduction and Robust Data Segment Growth Drive Margin Expansion
Deluxe reported a strong third quarter with organic growth across all key financial metrics including revenue, adjusted EBITDA, EPS, and cash flow. The company achieved its year-end leverage ratio tar...
- Deluxe achieved its year-end 2025 leverage ratio target of 3.3x a full quarter early, reflecting strong cash flow and disciplined debt reduction.
- Third quarter comparable adjusted revenue grew 2.5%, driven by a 46% surge in the data segment and 4.8% growth in merchant services.
- Adjusted EBITDA increased 13.8% year-over-year to nearly $119 million, with margins expanding 220 basis points to 22%.
- +17 more takeaways
TriplePoint Venture Growth BDC Q3 2025 Earnings Call - Record Funding and Strategic AI-Centric Portfolio Rotation
In Q3 2025, TriplePoint Venture Growth BDC (TPVG) marked a significant milestone with funding levels not seen since 2022, driven by robust demand from venture growth stage companies, particularly in A...
- Q3 2025 fundings hit highest levels since 2022, significantly exceeding guided range, driven by strong demand from venture growth companies.
- Almost $1 billion in signed term sheets over the past three quarters at TriplePoint Capital, with a near-record high pipeline since 2021.
- Venture capital deal activity surged, fueled by AI investments accounting for over two-thirds of deal value, signaling a strong recovery in the VC ecosystem.
- +10 more takeaways
Peakstone Realty Trust Q3 2025 Earnings Call - Strategic Shift Pays Off with IOS Portfolio Driving Growth and Debt Reduction
Peakstone Realty Trust's Q3 2025 earnings call showcased significant progress in its strategic transformation into a specialized industrial outdoor storage (IOS) REIT. Industrial assets now generate o...
- Peakstone has shifted focus into industrial outdoor storage (IOS), which now accounts for over 60% of annual base rent (ABR) as of October 31, 2025.
- The company has reduced total debt by approximately $450 million through office asset sales and proactive balance sheet management, lowering pro forma leverage to 5.4 times net debt to adjusted EBITDA RE.
- Remaining office portfolio shrank to 12 properties with expected sales proceeds of $300-$350 million by early 2026; $250-$300 million of those proceeds will be used to pay down debt further.
- +12 more takeaways